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Abstract
Background: A wide range of pharmaceutical products are needed for diagnosis, treatment, and prevention of
HIV/AIDS. However, interrupted supplies and stock-outs are the major challenges in the supply chain of ARV
medicines and related commodities. The aim of this study was to assess the supply chain management of HIV/AIDS
related commodities in public health facilities of Addis Ababa, Ethiopia.
Methods: A descriptive cross-sectional survey complemented by qualitative method was conducted in 24 public
health facilities (4 hospitals and 20 health centers). A semi-structured questionnaire and observation check list were
used to collect data on HIV/AIDS related service, reporting and ordering; receiving, transportation and storage
condition of ARV medicines and test kits; and supportive supervision and logistics management information system.
In addition, in-depth interview with flexible probing techniques was used to complement the quantitative data
with emphasis to the storage condition of ARV medicines and test kits. Quantitative data was analyzed using SPSS
version-20. Analysis of qualitative data involved rigorous reading of transcripts in order to identify key themes and
data was analyzed using thematic approach.
Results: The study revealed that 16 health centers and one hospital had recorded and reported patient medication
record. Six months prior to the study, 14 health centers and 2 hospitals had stopped VCT services for one time or
more. Three hospitals and 18 health centers claimed to have been able to submit the requisition and report
concerning ARV medicines to Pharmaceutical Fund and Supply Agency according to the specific reporting period.
More than three-fourth of the health centers had one or more emergency order of ARV medicines on the day of
visit, while all of hospitals had emergency order more than 3 times within 6 months prior to the study. All of the
hospitals and nearly half of the health centers had an emergency order of test kits more than 3 times in the past
6 months. Overall, nearly 3/4th of the health facilities faced stock-out of one or more ARV medicines and test kits
on the day of visit.
Conclusion: There was no adequate data on patient medication record and stock status of HIV/AIDS related
commodities. Moreover there were frequent stock-outs of ARV medicines and HIV test kits, which was an indicator
of the weak supply chain management. Hospitals and health centers, therefore, should devise a system to capture
and make use of patient medication record and stock status information so as to ensure continuous supply of the
commodities.
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Background
The human immune virus (HIV) epidemic remains a
major global public health challenge including in
Ethiopia. According to the 2014 estimate, Ethiopia had
793,700 people living with HIV with 15, 700 new HIV
infections and 35, 600 AIDS-related deaths. The national
HIV prevalence was 1.14 % in 2014 and it is declining
significantly varying by age, gender and geographical
location [1].
In the early 1980s when the AIDS epidemic began,
people living with HIV were not likely to live more than
a few years [2]. However, with the development of safe
and effective medicines, HIV positive people now have
longer and healthier lives [2, 3]. Initially, resource
limited countries could not afford to provide antiretroviral
therapy (ART) for their populations, and the life expect-
ancy of HIV positive people remained low [4]. However,
efforts have been made to make it more affordable within
low- and middle-income countries [3, 5].
Supply chain management of essential health com-
modities, including high-value medicines like Antiretro-
viral (ARV) medicines, involves a series of activities to
guarantee the continuous flow of products from the
manufacture to consumers [6]. The nature of ART and
the specific characteristics of ARV medicines and how
they are used pose particular challenges for managing
the supply chain for ARV medicines [7].
Effective pharmaceutical supply management and in-
ventory control avoid stock out, loss due to unnecessary
expiry, theft and ensure that the desired pharmaceutical
products are available at all times in adequate quantity
[8]. But in many low and middle income countries
(LMICs), the capacity of the pharmaceutical supply
management system has always been challenging and
weak. The ARV supply chain management has become
increasingly difficult due to increasing number of people
on ART, increasing number of sites providing ART and a
greater diversity of different ARV regimen [9].
Moreover, there are certain common challenges asso-
ciated with the quantification of ARV medicines and
supplies mainly in LMICs. Data on ART services and
ARV medicine supply are limited and when available,
are often unreliable or insufficient to be used for quanti-
fying ARV medicine requirements [7]. An accurate
quantification based on reliable data is essential for all
health commodities but more so for HIV/AIDS related
commodities because uninterrupted access for patients
must be ensured [9]. A pilot study done in Ethiopia,
however, showed that out of the 48 hospitals and
health centers, 10(21 %) of the institutions didn’t have
HIV medicines and out of 27 health posts, 9 (33 %)
did not have rapid diagnostic tests [10]. This shortage
of critical medicines and supplies in health facilities
may compromise appropriate clinical management
which ultimately increases mortality and development
of resistance pathogens causing a detrimental public
health impact [11].
One of the major reasons that medicines are wasted is
that they may have expired without anyone noticing that
the shelf life date was approaching. This type of lose,
however, is not acceptable to pharmaceuticals such as
ARV medicines, which are very expensive [8]. Besides,
due to poor handling of the available medicines and
other pharmaceutical products by the patients and pro-
fessionals, there is also a great loss of resources.
In addition to this, the 2010 World Health Organization
(WHO) guideline and the latest 2010 Ethiopian standard
treatment guideline recommend that ART should be initi-
ated when the CD4 count falls below 350/μl for WHO
stage 3 disease and should be initiated irrespective of CD4
count for stage 4 disease. If CD4 count is not available it
should be initiated irrespective of total lymphocyte count
[4, 12]. So it may lead to a drastic increase of the number
of patients who are eligible for ART and thus creating an
enormous burden to national health care system and
health facilities [13, 14].
Assessing the supply chain of ARV medicines and HIV
test kits is indispensible to improve access and thus pro-
vide quality services. Little has been done in this regard.
However a pilot study done by Daniel et al. (10) tried to
assess the availability of HIV medicines but did not ad-
dress the other components of the supply chain manage-
ment. This study was therefore conducted with the aim
of comprehensively assessing the supply chain manage-
ment of HIV/AIDS related commodities in public health
facilities of Addis Ababa, Ethiopia.
Methods
A descriptive cross-sectional survey employing both
quantitative and qualitative data collection technique
was conducted in the selected public health facilities. All
public health facilities providing voluntary counseling
and testing (VCT), prevention of mother to child trans-
mission (PMTCT) and ART services were the source
facilities of the study. All healthcare professionals work-
ing in ART clinic of the selected health facilities and all
documents that were used to manage the supply chain
of HIV/AIDS related commodities were used as sources
of information.
The numbers of health facilities to be included in the
study were calculated by using the Logistic Indicators
Assessment Tool (LIAT) for ARV medicines and Test
kits [14, 15]. At the time of survey, a total of 11 public
hospitals and 37 health centers were providing ART and
VCT services. Of these, 20 health centers; two from each
of the ten sub-cities where one health center with the
highest number of patients on ART treatment and the
other with the lowest patients burden were selected for
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the study. Selection of study hospitals was also done
based on their ownership and patient burden i.e. hospi-
tals were administratively stratified into those adminis-
tered by the Regional Health Bureau and the Federal
Ministry of Health (FMoH) and then selection of the
health facilities was made by extreme sampling. Accord-
ingly four governmental hospitals, two from FMoH and
two from Regional Health Bureau, were included in the
study. Two of the selected hospitals, one from each ad-
ministrative category, had the lowest patient load while
two of the remaining hospitals again one from each had
the highest burden of patients.
A semi-structured questionnaire and observation
check list were used to collect the quantitative data. A
modified version of the LIAT for ARV medicines and
test kits was used as a data collection tool [15, 16]. A
total of 14 ARV medicines and five HIV test kits were
selected for this assessment. A six month data (May
2013 to October 2013) were taken from bin card and
VCT daily register to see the pattern of VCT service and
stock status in hospitals and health centers. VCT daily
register, ARV medicines and patient information sheets
(PIS), ARV medicines dispensing register, patient
tracking charts, ARV medicines dispensing register for
post exposure prophylaxis, ARV medicines dispensing
register for emergency supply, medicine reporting and
requisition format (RRF), Model 19 (receiving voucher),
bin card, medicine and supply expiry date tracking charts
and temperature recording charts were the major
documents checked and reviewed to get the required
information.
An in-depth interview with flexible probing techniques
was designed to collect the qualitative data from the key
informants. The head of pharmacy departments, ART
store managers, ART dispensers, Laboratory heads, VCT
staff and ART coordinator from the selected hospitals
and health centers were purposively identified as key
informants for the study.
After the data was manually checked for completeness
and consistencies, it was entered and analyzed by using
SPSS version 20. Descriptive statistics including mean,
percentage and standard deviations was used to present
the quantitative data. The qualitative data analysis in-
volved an intensive reading through the interview in
order to identify key themes. Audio-recorded inter-
views were transcribed verbatim and the raw data
was categorized under pre-developed coded themes
and sub themes. A thematic analysis was then used
to analyze the data.
Ethical approval was obtained from the Ethics Review
Board of the School of Pharmacy, Addis Ababa Univer-
sity, Addis Ababa Regional Health Bureau and from the
respective health facilities. Besides, a verbal consent was
obtained from all participants before starting the actual
data collection. Confidentiality and anonymity of infor-
mation was maintained throughout the data collection




A total of 24 health facilities were visited during this as-
sessment; of which 4 were hospitals and 20 were health
centers. All selected facilities were providing VCT,
PMTCT and ART services. The selected health centers
had an experience on VCT service provision for an aver-
age of 9.1 years (SD = 1.4 and range from 6 to 11 years)
and ART service provision for a mean period of 6.9 years
(SD = 0.8 and range from 5 to 8 years); while hospitals
had longer experience of providing VCT and ART ser-
vices, 10.3 years (SD = 1.5 and range from 9 to 12 years)
and 9 years (SD = 1.6 and range from 7 to 11 years)
respectively.
A majority (65 %) of the health centers and half of the
hospitals were not providing VCT service on the day of
visit. Moreover, the VCT service was interrupted at least
once in 14(70 %) of the health centers and 2(50 %) of
the hospitals within six months prior to the commence-
ment of the survey. When facilities had shortage of HIV
test kits, they conducted tests only for emergency cases
or for PMTCT. In the past six months prior to the
study, VCT service was not provided by the health cen-
ters for longer period which averaging 39.8 ± 32.8 (range
from 0 to 98) days compared to hospitals, 6.8 ± 11 (range
from 0 to 23) days. Mostly the interruption was associ-
ated with stock-outs of HIV (1 + 2) Antibody Colloidal
Gold (KHB) but shortage of stat pack and blood lancet
were also mentioned as additional factors.
Regarding the ART services, majority (80 %) of the
health centers and all of the hospitals had lists of recom-
mended ARV medicine regimens to be prescribed and
dispensed. A majority 16(80 %) of the health centers and
only one hospital knew and reported their patient medi-
cation record. The rest, 4 health centers and 1 hospital
were using ART clinic data to report to higher level.
Two hospitals claimed that they were reporting the data
from the ART pharmacy without retaining the copy of
the reported data.
The key informants’ interview with the heads of phar-
macy departments and the data clerks in two of the hos-
pitals revealed that their Electronic Dispensing Tool
(EDT) was not working appropriately and thus both the
ART pharmacist and the data clerk were facing difficul-
ties in using the patient database. In addition to this,
they said that they wouldn’t use any paper based format
to register patient data because of high patient burden.
In another hospital, the head of the pharmacy and the
ART pharmacist mentioned that they were only able to
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enter patient information without analyzing the data for
further reporting. In addition to this, they also men-
tioned that due to negligence of the professionals and
other factors, the data in EDT was not reliable. Even
though they have been using PIS, they didn’t use it
appropriately.
All of the health facilities had EDT to dispense medi-
cines to the patient and all, except one, of them were ap-
plying the EDT in their daily work. A majority 19(95 %)
of health centers and 3/4th of the hospitals used both
EDT and PIS to record the amount of medicines dis-
pensed to the patients and other patient information.
But, Dispensing Register was available and used only in
14 health centers and none of the hospitals. A majority
of them had been dispensing a dose that ranges from
15 days to 3 months, depending on patients’ condition.
Erratic supply of medicines in some health facilities,
however, was reported by the ART pharmacists that
forced them to dispense medicines for a week, 3 days
and even for a day; especially for TDF/3TC based regi-
men. Sometimes, they mentioned that they even referred
patients to other health facilities.
Eighteen health centers and 2 hospitals used separate
register for post exposure prophylaxis and for emer-
gency. Patient Tracking Chart was being used by only 10
health centers and 2 hospitals. Nevertheless, absentee
patients tracked by this chart were not called to attend
the health facility mainly due to lack of telephone in
these health facilities.
Reporting and ordering ARV medicines and HIV test kits
Store manager in one of the 20 health centers was not
available during the study time and hence 19 key infor-
mants from the health centers and 4 from hospitals were
considered. All health facilities reported using RRF to re-
port consumption and order ARV medicines from the
Pharmaceutical Fund and Supply Agency (PFSA) Re-
gional Hub.
In a majority (89.5 %) of the health facilities, RRF was
prepared and reported by the store manager alone. Thus,
the store managers were responsible for determining the
quantity of medicines. In the rest of the facilities, both
the store manager and the head pharmacist claimed to
have been involved in quantification. A majority (94.7 %)
of the health centers and 3/4th of hospitals’ store man-
agers claimed that they had submitted their last report
according to the schedule. A majority of the store
managers 15(78.9 %) in health centers and 3(75 %) in
hospitals had training on integrated pharmaceutical
logistic system (IPLS).
A majority of the facilities had emergency orders in
the past 6 months prior to the study. Only 3(15.8 %) of
the health centers didn’t have emergency orders. On the
other hand, all of the hospitals reported that they had
emergency orders for more than 3 times within 6 months
prior to the study (Table 1).
The reporting and requisition of test kits was done in
combination with the ARV medicines by the main store
manager in all the studied health facilities except one
hospital and two health centers. The hospital had a sep-
arate store for test kits, so the RRF was prepared by sep-
arate store manager. In the two health centers the RRF
was prepared by the laboratory head that never had
training for the purpose. All hospitals reported the use
of standard method to determine the quantity of HIV
test kits but only 9(47.3 %) of the health centers did use
the same during the quantification process. Most health
centers mentioned the practice of rough estimation since
they were unable to calculate the exact quantity of test
kits due to frequent supply interruption. Generally, the
reporting and the requisition of HIV test kits were more
organized in hospitals compared with health centers.
All health facilities, except one, had emergency order
of test kits in the past six months prior to the study. All
of the hospitals and nearly half (47.4 %) of the health
centers had an emergency order for more than three
times in the past six months. They all agreed that in the
majority of the cases they received the test kits on emer-
gency order (Table 1).
Receiving and transportation of ARV medicines and test kits
All of the hospitals reported that they were not always
getting the required quantity of ARV medicines and only
1 of the health center was always able to get the
Table 1 Frequency of emergency orders for ARV drugs and HIV
test kits in the health facilities, Addis Ababa, 2013
Proportion by type of health facility
Health centers; n (%) Hospitals; n (%)
Frequency of emergency orders encountered
for ARV in the last 6 months
No emergency order 3(15.8) 0 (0.00)
One emergency order 4(21.1) 0 (0.00)
Two emergency orders 2(10.5) 0 (0.00)
Three emergency orders 6(31.6) 0 (0.00)
More than three emergency
order
4(21.1) 4(100)
Frequency of emergency orders encountered
for HIV test kits in the last 6 months
No emergency order 1(5.3) 0 (0.00)
One emergency order 3(15.8) 0 (0.00)
Two emergency orders 2(10.5) 0 (0.00)
Three emergency orders 2(10.5) 0 (0.00)
More than three emergency
order
9(47.4) 4(100)
Do not know 2(10.5) 0 (0.00)
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quantified amount (Table 2). Regarding the average time
interval between ordering and receiving of the medi-
cines, three-fourth of the hospitals and 13(68.4 %) of the
health centers received the products ordered between
two weeks to one month of their order point (Table 2).
But review of the health facilities’ last report had
showed that, on average the lead time was 37.5 ±
17.1 days and 34.2 ± 18 days in hospitals and health
centers, respectively.
During the last order time, the average number of
ordered ARV product was found to be 6. The mean
percentage difference between quantity ordered and re-
ceived was high for 3TC300/TDF300 (69.6 % ±17 %,
(55 %, 93 %)) and D4T12/3TC60 (69.4 % ± 33.3 %,
(45.8 %, 93 %)) in hospitals while it was high for D4T6/
3TC30/NVP 50 (110.9 % ± 193.8 %, (0 %, 400 %)) and
3TC300/TDF300 (51.7 % ± 33.8 %, (0 %, 99 %)) in health
centers for last report period (Table 3).
Supportive supervision
All of the health centers and 3/4th of the hospitals were
supervised by professionals from the Regional Health
Bureau or FMoH during the past 6 months prior to the
study. The study also showed that only 2 of the hospitals
and a quarter of the health centers had received support-
ive supervision more than 3 months ago. All of the re-
spondents said that their last supervision included
review of stock cards and bin cards, physical stock
count, storage condition, review of health commodity in-
formation management system (HCMIS) and EDT, PIS
and dispensing register book, VCT tally and VCT daily
register. They also discussed and facilitated removal of
expired products from the stores.
Storage condition of ARV medicines and test kits
The stores of 19 health centers and 4 hospitals were
assessed during the study time. There were 2 health
centers which didn’t have a bin card for ARV medicines
and not included in the calculation of percentage of bin
card updated. There were also 2 hospitals, which had
updated bin card with 1 month and 2 months transac-
tion; which were included in the calculation of availabil-
ity of bin card for ARV medicines and bin card updated.
But these two hospitals had no complete transaction for
the past 6 months. Store manager of one of the hospital
had a complete bin card of 9 ARV medicines, so only
the bin card of the 9 products were used in the past
6 month stock status. The store manager of the second
hospital didn’t record the past 14 months transaction
neither on bin card nor on the HCMIS; and thus the
hospital was excluded in the calculation of past six
months stock status of ARV medicines. The stock status
was then calculated with these limitations.
Overall, 14(73.7 %) of the health centers and 3(75 %)
of the hospitals had stock out of one or more ARV
medicines on the day of visit. All of the hospitals and
health centers faced stock out of 1 or more ARV
medicines in the past months prior to the study time.
EFV600, NVP200, NVP240 and D4T6/3TC30/NVP50
were stocked out both at hospitals and health centers.
The average number of products which were out of
stock on the day of visit was 1.6 and 2.0 in health cen-
ters and hospitals respectively and it went as high as 6
and 4 in health centers and hospitals respectively. Mean
number of out of stock products in the past six months
prior to the study was 5.1 and 6.5 in health centers
and hospitals, respectively (Table 4). The most fre-
quent out of stock item in the past 6 months prior to
the study in the health facilities was TDF300/3TC300.
The mean duration of stock out was longer for D4T6/
3TC30 (55.8 ± 45 days, (0, 109)) and TDF300/3TC300
(45.9 ± 45.5 days, (0, 165)) in health centers while it was
long for TDF300/3TC300 (42.5 ± 60.1 days, (0, 85)) and
NVP200 (36.5 ± 19.1 days, (23, 50)) (Table 3).
Decreasing the ordered quantity of ARV medicines and
test kits by the supplier was mentioned as a main reason
for the stock outs of these pharmaceuticals. In addition to
this, respondents claimed that the transfer of patients
from D4T to TDF/3TC based regimen was a major con-
tributing factor for shortage of TDF300/3TC300.
According to majority of the store managers, stock
movement was controlled using both bin card and
HCMIS. Except 2 (10.5 %) of health centers; all of the
health facilities used bin card on the day of visit. Besides,
all health facilities used maximum-minimum stock control
system to manage the stock of ARV medicines and as
a result they were supposed to have maximum stock
of 4 months, minimum stock of 2 months and an
emergency stock of 15 days.
During the time of visit, average percentage of updated
bin cards were 85.7 % in health centers and 96.9 % in
Table 2 Frequency of receiving the ordered quantity of ARV
drugs and Average lead time for ARVs in hospitals and health
centers, Addis Ababa, 2013
Health centers; n (%) Hospitals; n (%)
How frequently did you receive the amount of ARV drugs you ordered?
Always 1 (5.3) 0 (0.00)
Most of the time 12 (63.2) 1 (25.0)
Sometimes 6 (31.6) 3 (75.0)
Never 0 (0.00) 0 (0.00)
Average lead time between ordering and receiving ARV drugs
Less than two weeks 3 (15.8) 1 (25.0)
2 weeks to 1 month 13 (68.4) 3 (75.0)
1 month to 2 months 2 (10.5) 0 (0.00)
More than 2 months 1 (5.3) 0 (0.00)
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hospitals. Percentage of bin card updated varied from
facility to facility with a range of 22.2– 100 % in health
centers and 87.5–100 % in hospitals. All bin cards were
updated in 3(75 %) of the hospitals and 10(58.8 %) of
health centers. While the remaining hospitals and health
centers had one or more un-updated bin cards.
Regarding the selected HIV test kits, (KHB, stat-pack,
Uni-gold, blood lancet and EDTA capillary tube), at the
time of the assessment only 10(52.6 %) of health centers
and 2(50 %) of hospitals had a bin card. Regarding the
stock status of test kits, 10(52.6 %) of the health centers
reported stock-out of 1 to 3 test kits and all hospitals
had stock out of 1 or 2 test kits. In a majority of the
health centers and hospitals, Uni-Gold was out of stock
on the day of visit more than other kits (Fig. 1). Average
percentage of test kits which were out of stock on the
day of visit was 29.5 % and 35 % in health centers and
hospitals, respectively.
Except one hospital, all of the facilities had one central
store for ARV medicines and test kits. The qualitative
data obtained from observation checklist showed that
appropriate arrangement of products with visible expiry
dates and identification labels, first expired first out
(FEFO) organization of product and accessibility of
products for counting; cleanliness of the store, and
thermometer usage were the major challenges identified
in majority of the health facilities. Lack of ventilation, in-
adequate light of the store room and inadequacy of stor-
age space were observed in a majority of the health
centers and few hospitals. The stores in a majority of the
health centers were highly overfilled and products were
kept in a direct floor without a pallet. In addition, there
was sign of rodents and insects in the majority of health
centers and few of the hospitals.
It was also observed that, utilization of expiry tracking
chart was very minimal both in the health centers and
Table 3 Stock-out status of ARVs within 6 months prior to the study and percentage difference between ordered and received
quantities of ARVs in health centers and hospitals, Addis Ababa, 2013
ARV drugs Stock-out days of ARVs within 6 months
prior to the study
Percentage difference between ordered and received
quantities of ARVS
Health centers Hospitals Health centers Hospitals
Average number
of days ± SD
Average number
of days ± SD
Mean percentage
difference ± SD
(Min, Max) Mean percentage
difference ± SD
(min, max)
EFV50 12 ± 21 0 0 0 a a
EFV200 10.1 ± 28 0 9.5 ± 21.2 (0, 47.6) 0 0
EFV600 18.8 ± 25 0 47 ± 32.3 (0, 80.7) 2.9 ± 2.7 (0, 11.5)
3TC300/TDF300 45.9 ± 45.5 42.5 ± 60.1 51.7 ± 33.8 (0, 99) 69.6 ± 17 (55, 93.4)
NVP 200 16.6 ± 30.8 36.5 ± 19.1 0 0 0 0
ZDV300/3TC150 9.7 ± 13.9 34.5 ± 14.8 27.1 ± 43.1 (0, 143) 34 ± 29.5 (0, 52)
ZDV300/3TC150/NVP200 13 ± 19.9 20.5 ± 4.9 14.8 ± 33.6 (0, 93.6) 50 ± 0 (50,50)
3TC30/ZDV60/NVP50 15 ± 17 0 0 0 0 0
NVP 240 ml 33.7 ± 46.7 29 ± 41 5.9 ± 16.6 (0, 47.1) 0 0
D4T12/3TC60/NVP100 20.1 ± 25 27 ± 0.0 27.8 ± 83.5 (0, 290) 0 0
D4T6/3TC30/NVP50 16.8 ± 24.4 0 110.8 ± 193.8 (0, 400) 0 0
3TC30/ZDV60 14.8 ± 21.8 16.5 ± 14.8 25.4 ± 35.9 (0, 50.8) 45.7 ± 12.7 (36.7,54.7)
D4T 12/3TC60 15.6 ± 33.1 0 0 0 69.4 ± 33.3 (45.8,93)
D4T 6/3TC30 55.8 ± 45 0 a a 0 0
ameans the product was not ordered by the health facility in last requisition and reporting reviewed
D4T = Stavudine; EFV = Efavernez; NVP = Nevirapine; TDF = Tenofovir; 3TC = Lamivudine; ZDV = Zidovudine
Table 4 Proportion of ARVs managed and stocked out in in the health facilities on the day of visit and within 6 months prior to the
study, Addis Ababa, 2013
On day of visit The past 6 months
Health centers Hospitals Health centers Hospitals
Mean ± SD (Min, Max) Mean ± SD (Min, Max) Mean ± SD (Min, Max) Mean ± SD (Min, Max)
No. of ARVs managed 12.2 ± 2 (8,14) 13.2 ± 3.8 (8,16) 12.2 ± 2 (8,14) 13.2 ± 3.8 (8,16)
No. of ARVs stocked out 1.6 ± 1.5 (0,6) 2 ± 1.6 (0,4) 5.1 ± 2.6 (1,11) 6.5 ± 2.1 (5,8)
% of ARVs stocked out 12.8 ± 11.3 (0,42.8) 17 ± 13.7 (0,30.8) 46.3 ± 23.3 (9.1,91.7) 56.3 ± 8.8 (50,62.5)
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hospitals. Expired medicines and test kits were found on
the shelves of some of the health centers and one hos-
pital. On the contrary, majority of the health centers and
hospitals were able to maintain the outer cartoon of the
product in a good condition and they were able to separ-
ate the expired and damaged product from usable prod-
uct either in the store room or in separate store.
Moreover, the observation revealed that cartoons and
products were protected from direct sunlight; stores
were locked and the keys were maintained with the store
manager, roofs were maintained in good condition to
avoid sunlight and water penetration.
Logistic management information system
For majority of the health centers and hospitals, EDT
was the main tool to record patient information even
though there was risk of power interruption and risk of
losing the patient data. EDT contains all the medicines
currently dispensed at facilities unlike HCMIS. Since there
is large number of HIV/AIDS patients, this computerized
software eases the work of the health professionals and
the data clerks at the dispensary. However, the profes-
sionals had reported drawbacks of the software; not easy
to manipulate and get patient data by regimen type. So
when the need arises, they relied on the data obtained
from the clinic which had also some shortcomings.
Problem of data quality was also reported by majority
of the health facilities. Only one health center was able
to correctly report the ending balance as the stock on
hand found in the central store room as well as in all
other dispensing units, while the rest of the health facil-
ities wrongly reported the ending balance as stock on
hand kept in the store room only. Besides, deliberate
manipulation of recording was reported by one store
manager as there were cases where the supplier sent ex-
cess ARV medicines and thus the manager targeted to
decrease the ordered ARV medicines. Hence, to prevent
and minimize the fluctuations made by the supplier, the
store manager of the health centers increased or de-
creased the balance to be reported accordingly.
Discussion
Although information about patients taking ARVs medi-
cine by regimen data is crucial for the medicine supply
chain management, it was only 16 (80 %) of the health
centers and one hospital that were able to know the pa-
tient medication record data and reported appropriately.
The main problem was related to inefficiency of the
EDT and as a result some of the health facilities were
using the ART clinic data as an alternative. Nevertheless,
the report from the ART clinic lacked patient data on
TDF/3TC/EFV and TDF/3TC/NVP; where these two
medicines accounted near to quarter or more of the pa-
tients in the health facilities and other second line ARV
medicines. Thus, this lack of adequate and accurate data
might affect quantification and procurement planning
for ARV medicines. Similarly, a study done by Al1ers
et al. showed that, data on ART services and ARV
medicine supply were limited and, when available, are
often unreliable or insufficient to be used for quantify-
ing ARV medicine requirements [7]. Another literature
stressed the importance of information in medicine
supply chain management to ensure that there are no
interruptions in treatment and tests [5].
Adherence is an important issue in any antibiotic ther-
apy but it is of a special concern when it comes to medi-
cines like ARVs. HIV patients should be monitored and
followed with much of concern. In this regard, the use
of patient tracking chart is vital tool to monitor the ad-
herence and thus recommended by the standard operat-
ing procedure for management of ART medicines in
health facilities [8]. The present study, however, showed
that only half of the health centers and hospitals had
been using patient tracking chart. In those facilities
which didn’t use patient tracking chart, medicines were
simply dispensed to patients who came to their dispens-
ary but they didn’t know how much of their patients
were missed and treatment adherence is left to the pa-
tients. This practice could contribute to default of more
patients, probably emergence of medicine resistance and
loss of lives.
Fig. 1 Proportion of health facilities stocked out of HIV test kits on the day of visit in the, Addis Ababa, 2013
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Our study also documented that in the studied health
facilities, ART dispensers were dispensing doses that
range from 15 days to 3 months depending on the pa-
tient’s condition. Frequent stock-out of medicines and
regimen change from D4T to TDF/3TC which is associ-
ated with shortage of TDF/3TC, however forced them to
dispense medicines even for a single day. The percentage
difference between quantities ordered and received was
high for TDF/3TC both in health centers and hospitals.
Such high percentage difference between ordered and
received quantity was an indicative of interrupted supply
chain. This kind of practice therefore might exhaust the
patients and contribute for default. The present study
result mirrors to a study in Mali, where forecasting be-
came difficult due to shifting of patients to alternative
first line and second line ART regimens [9].
Accurate quantification of HIV/AIDS related com-
modities is a complex process confined with multifa-
ceted factors [17]. The present study revealed that even
though both health centers and hospitals control their
inventory using maximum-minimum stock inventory
control system, frequent emergency order of ARV medi-
cines was reported in the six months prior to the study.
A majority of the health centers had one or more emer-
gency orders while all of hospitals had emergence orders
of ARV medicines more than three times. This might be
associated with the relatively higher number of patients
in hospitals than health centers.
This study also showed that only half of the hospitals
and a quarter of the health centers had received recent
supportive supervision more than 3 months ago. So, lack
of planned and timely supportive supervision may also
become a challenge in ensuring adequate supplies. A
study done in Lesotho similarly revealed that there were
challenges in the medicine supply management system,
which were mainly due to the lack of supervisory site
visits, leading to facilities over-stocking or under-stocking
of certain items [18].
Failure to observe expiry dates of medicines might lead
to the loss of a significant amount of resources, espe-
cially in resources limited countries. This type of loss is
not acceptable to pharmaceuticals such as ARV medi-
cines, which are very expensive [8]. Contrary to this fact,
the present study showed that utilization of expiry track-
ing chart was minimal in health facilities and thus on
the day of visit, expired medicines and test kits were
found on the shelves of the health facilities. Similar to
this finding, a study done in Lesotho showed that, ARV
medicines were expired on the shelves in some facilities
where inventory was poorly managed [18].
The present assessment also indicated that more than
three fourth of the hospitals and health centers had
stock-out of one or more ARV medicines on the day of
visit and during the past 6 months preceding the survey
date. TDF300/3TC300 was most frequent stock out item
in the past 6 months both in hospitals and health centers.
Mean number of stock out products in the past 6 month
was 5.1 and 6.5 in health centers and hospitals, respect-
ively. The percentage of products which were out of stock
was 12.8 % and 17 % in health centers and hospitals, re-
spectively. Regarding the test kits, all of the hospitals and 2
of the health centers reported stock out of one or more test
kits on the day of visit. Different from this study, a study
done in Oromia National Regional State showed that avail-
ability of first line ARV medicines was 100 % in health cen-
ters and 95 % in hospitals [19]. Another study done in
Ethiopia also showed that stock outs for ARVs had been
non-existent or minimal [14]. An assessment done in
Sierra Leon similarly showed that there were stock-outs of
EFV and second line medicines in ART providing facilities
[7]. Concur to our finding, a study done in Uganda showed
that, ARV shortages affected all ART providing facilities
with considerable fluctuations. ARVs were available at 83 %
and diagnostic kits at 70 % of the health facilities surveyed
[20]. Similarly, Jonathan et al., showed that interrupted
supplies and stock outs were the major challenges in the
supply chain of ARV medicines in Africa [21].
Interruption of the supply of these medicines put indi-
vidual patient at risk of disease progression and death, in
medicine resistance development, hampers progress to-
wards universal access, and diminishes the credibility of
ART programs in the eyes of patients, community and
healthcare providers and inadvertently putting the public
health in danger [10]. So to prevent this kind of inter-
ruption, there has to be efficient supply chain. Effective
medicine supply chain management and inventory con-
trol would help to avoid or at least minimize stock-outs,
losses due to unnecessary expiry, theft and ensure that
the desired pharmaceutical products are available at all
times in adequate quantity [8].
Except 2 (10.5 %) of health centers; all health centers
and hospitals used bin card for ARV medicines on the
day of visit. Availability and practice of updating of the
bin cards was relatively better in hospitals than health
centers. Unlike ARV medicines, only 10(52.6 %) of
health centers and 2(50 %) of hospitals had a bin card
for the selected test kit on the day of visit. Consistent to
this findings, a study done in Sierra Leone reported that
the stock keeping practice in ART providing health
facilities was not good where no bin cards were available
for any of the ARV medicines or HIV test kits at any of
the health facilities visited [22]. Contrary to the present
findings, however, a 2009 evaluation done in Ethiopia
indicated that the inventory control in all surveyed
ART sites and use of bin cards and stock cards was
found to be adequate [14].
To provide clients with high quality products and en-
sure efficient handling and use of products, each facility
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must have safe, protected and organized storage areas.
The present assessment however, revealed that the storage
facilities both in hospitals and health centers were far from
adequate. The store premises and storage conditions were
better in hospitals compared to health centers. Similarly, a
study done in Sera Leon also stated that the storage condi-
tion observed in district and primary healthcare units was
not generally in a good condition where expired medicines
and kits were stored together with the usable commodities
causing shortage of space in the health facilities [22].
An evaluation done in Ethiopia similarly showed that
there were inadequate storage facilities, management,
capacity, and temperature monitoring, especially for
the cold chain [14].
The health facilities in Addis Ababa had both com-
puterized and paper based LMIS. However, a majority
of the health facilities had problems with the use of
the automated LMIS. According to them, some fea-
tures of the software were not easy to manipulate and
fix the problem. As a result, relying on the computerized
LMIS leave majority of the health facilities with incom-
plete and inaccurate data in both dispensary and store
areas. A study suggested that computerized LMIS can
greatly facilitate the work of supply chain managers and
hence there is urgency to introduce user-friendly tools
and software to support the management of logistics in-
formation system in the health facilities [23].
Conclusions
ART and VCT services started in Ethiopia over a decade
ago. However, data on patient medication record and
stock status of ARV medicines and Test kits is still inad-
equate. The present study demonstrated that a majority
of the facilities in Addis Ababa didn’t have patient track-
ing chart and consequently treatment adherence seemed
to be left to the patients themselves. The reporting and
receiving system of ART medicines were relatively more
organized compared to HIV test kits in the studied
health facilities. Though the stock status of ART medi-
cines were controlled relatively in better way than HIV
test kits, shortages of both commodities were common
in both health centers and hospitals. Of all commodities;
TDF/3TC, KHB and Uni-gold were the major out of
stock items in the supply chain. For example, more than
half of the health facilities were not providing VCT ser-
vice on the day of our visit mainly due to lack of KHB.
The storage condition of these commodities was not
good but it was relatively better in hospitals than health
centers. On the other hand, the stores and ART phar-
macy sections of all health facilities had computerized
LMIS. However, majority of the professionals who were
supposed to run the system claimed that they were un-
able to manipulate and operate the software efficiently.
Hence, introducing user-friendly tools and software is
essential to support the management of logistics infor-
mation system in the health facilities.
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